Free fatty acid metabolism in human obesity

Christina Koutsari, Michael Dennis Jensen

Research output: Contribution to journalArticle

129 Citations (Scopus)

Abstract

Adipose tissue lipolysis provides circulating FFAs to meet the body's lipid fuel demands. FFA release is well regulated in normal-weight individuals; however, in upper-body obesity, excess lipolysis is commonly seen. This abnormality is considered a cause for at least some of the metabolic defects (dyslipidemia, insulin resistance) associated withupper-body obesity. "Normal" lipolysis is sex-specific and largely determined by the individual's resting metabolic rate. Women have greater FFA release rates than men without higher FFA concentrations or greater fatty acid oxidation, indicating that they have greater nonoxidative FFA disposal, although the processes and tissues involved in this phenomenon are unknown. Therefore, women have the advantage of having greater FFA availability without exposing their tissues to higher and potentially harmful FFA concentrations. Upper-body fat ismore lipolytically active than lower-body fat in both women and men. FFA released by the visceral fat depot contributes only a small percentage of systemic FFA delivery. Upper-body subcutaneous fat is the dominant contributor to circulating FFAs and the source of the excess FFA release in upper-body obesity. We believe that abnormalities in subcutaneous lipolysis could be more important than those in visceral lipolysis as a cause of peripheral insulin resistance. Understanding the regulation of FFA availability will help to discover new approaches to treat FFA-induced abnormalities in obesity.

Original languageEnglish (US)
Pages (from-to)1643-1650
Number of pages8
JournalJournal of Lipid Research
Volume47
Issue number8
DOIs
StatePublished - 2006

Fingerprint

Lipolysis
Nonesterified Fatty Acids
Metabolism
Obesity
Fats
Adipose Tissue
Tissue
Insulin Resistance
Availability
Insulin
Basal Metabolism
Intra-Abdominal Fat
Subcutaneous Fat
Dyslipidemias
Vascular Resistance
Fatty Acids
Lipids
Weights and Measures
Oxidation
Defects

Keywords

  • Fat distribution
  • Regional lipolysis
  • Resting energy expenditure
  • Sex
  • Subcutaneous adipose tissue
  • Visceral fat

ASJC Scopus subject areas

  • Endocrinology

Cite this

Free fatty acid metabolism in human obesity. / Koutsari, Christina; Jensen, Michael Dennis.

In: Journal of Lipid Research, Vol. 47, No. 8, 2006, p. 1643-1650.

Research output: Contribution to journalArticle

Koutsari, Christina ; Jensen, Michael Dennis. / Free fatty acid metabolism in human obesity. In: Journal of Lipid Research. 2006 ; Vol. 47, No. 8. pp. 1643-1650.
@article{2a9e77b38962444f81c9baa65a20bb73,
title = "Free fatty acid metabolism in human obesity",
abstract = "Adipose tissue lipolysis provides circulating FFAs to meet the body's lipid fuel demands. FFA release is well regulated in normal-weight individuals; however, in upper-body obesity, excess lipolysis is commonly seen. This abnormality is considered a cause for at least some of the metabolic defects (dyslipidemia, insulin resistance) associated withupper-body obesity. {"}Normal{"} lipolysis is sex-specific and largely determined by the individual's resting metabolic rate. Women have greater FFA release rates than men without higher FFA concentrations or greater fatty acid oxidation, indicating that they have greater nonoxidative FFA disposal, although the processes and tissues involved in this phenomenon are unknown. Therefore, women have the advantage of having greater FFA availability without exposing their tissues to higher and potentially harmful FFA concentrations. Upper-body fat ismore lipolytically active than lower-body fat in both women and men. FFA released by the visceral fat depot contributes only a small percentage of systemic FFA delivery. Upper-body subcutaneous fat is the dominant contributor to circulating FFAs and the source of the excess FFA release in upper-body obesity. We believe that abnormalities in subcutaneous lipolysis could be more important than those in visceral lipolysis as a cause of peripheral insulin resistance. Understanding the regulation of FFA availability will help to discover new approaches to treat FFA-induced abnormalities in obesity.",
keywords = "Fat distribution, Regional lipolysis, Resting energy expenditure, Sex, Subcutaneous adipose tissue, Visceral fat",
author = "Christina Koutsari and Jensen, {Michael Dennis}",
year = "2006",
doi = "10.1194/jlr.R600011-JLR200",
language = "English (US)",
volume = "47",
pages = "1643--1650",
journal = "Journal of Lipid Research",
issn = "0022-2275",
publisher = "American Society for Biochemistry and Molecular Biology Inc.",
number = "8",

}

TY - JOUR

T1 - Free fatty acid metabolism in human obesity

AU - Koutsari, Christina

AU - Jensen, Michael Dennis

PY - 2006

Y1 - 2006

N2 - Adipose tissue lipolysis provides circulating FFAs to meet the body's lipid fuel demands. FFA release is well regulated in normal-weight individuals; however, in upper-body obesity, excess lipolysis is commonly seen. This abnormality is considered a cause for at least some of the metabolic defects (dyslipidemia, insulin resistance) associated withupper-body obesity. "Normal" lipolysis is sex-specific and largely determined by the individual's resting metabolic rate. Women have greater FFA release rates than men without higher FFA concentrations or greater fatty acid oxidation, indicating that they have greater nonoxidative FFA disposal, although the processes and tissues involved in this phenomenon are unknown. Therefore, women have the advantage of having greater FFA availability without exposing their tissues to higher and potentially harmful FFA concentrations. Upper-body fat ismore lipolytically active than lower-body fat in both women and men. FFA released by the visceral fat depot contributes only a small percentage of systemic FFA delivery. Upper-body subcutaneous fat is the dominant contributor to circulating FFAs and the source of the excess FFA release in upper-body obesity. We believe that abnormalities in subcutaneous lipolysis could be more important than those in visceral lipolysis as a cause of peripheral insulin resistance. Understanding the regulation of FFA availability will help to discover new approaches to treat FFA-induced abnormalities in obesity.

AB - Adipose tissue lipolysis provides circulating FFAs to meet the body's lipid fuel demands. FFA release is well regulated in normal-weight individuals; however, in upper-body obesity, excess lipolysis is commonly seen. This abnormality is considered a cause for at least some of the metabolic defects (dyslipidemia, insulin resistance) associated withupper-body obesity. "Normal" lipolysis is sex-specific and largely determined by the individual's resting metabolic rate. Women have greater FFA release rates than men without higher FFA concentrations or greater fatty acid oxidation, indicating that they have greater nonoxidative FFA disposal, although the processes and tissues involved in this phenomenon are unknown. Therefore, women have the advantage of having greater FFA availability without exposing their tissues to higher and potentially harmful FFA concentrations. Upper-body fat ismore lipolytically active than lower-body fat in both women and men. FFA released by the visceral fat depot contributes only a small percentage of systemic FFA delivery. Upper-body subcutaneous fat is the dominant contributor to circulating FFAs and the source of the excess FFA release in upper-body obesity. We believe that abnormalities in subcutaneous lipolysis could be more important than those in visceral lipolysis as a cause of peripheral insulin resistance. Understanding the regulation of FFA availability will help to discover new approaches to treat FFA-induced abnormalities in obesity.

KW - Fat distribution

KW - Regional lipolysis

KW - Resting energy expenditure

KW - Sex

KW - Subcutaneous adipose tissue

KW - Visceral fat

UR - http://www.scopus.com/inward/record.url?scp=33745784213&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33745784213&partnerID=8YFLogxK

U2 - 10.1194/jlr.R600011-JLR200

DO - 10.1194/jlr.R600011-JLR200

M3 - Article

C2 - 16685078

AN - SCOPUS:33745784213

VL - 47

SP - 1643

EP - 1650

JO - Journal of Lipid Research

JF - Journal of Lipid Research

SN - 0022-2275

IS - 8

ER -